机构:[1]Department of Tumor Institute Yunnan Cancer Hospital Third Affiliated Hospital of Kunming Medical University, Kunming Yunnan Province, China[2]Department of Urology Institute of Urology West China Hospital Sichuan University, Chengdu Sichuan Province, China四川大学华西医院[3]Department of Clinical Cancer Research Center of Combination of Traditional Chinese and Western Medicine,Yunnan Cancer Hospital Third Affiliated Hospital of Kunming Medical University, Kunming Yunnan Province, China[4]Department of Radiotherapy,Yunnan Cancer Hospital Third Affiliated Hospital of Kunming Medical University, Kunming Yunnan Province, China[5]Department of Thoracic Surgery Yunnan Cancer Hospital Third Affiliated Hospital of Kunming Medical University, Kunming Yunnan Province, China[6]Department of Organ Transplantation Center First Affiliated Hospital of Kunming Medical University, Kunming Yunnan Province, China昆明医科大学附属第一医院
第一作者机构:[1]Department of Tumor Institute Yunnan Cancer Hospital Third Affiliated Hospital of Kunming Medical University, Kunming Yunnan Province, China
共同第一作者:
推荐引用方式(GB/T 7714):
Wang Yang,Liu ShengZhuo,Liu Shan,et al.Regorafenib Treatment for Management of Colorectal Cancer: A Systematic Review and Meta-analysis of 6 Randomized Controlled Trials[J].AMERICAN JOURNAL OF THERAPEUTICS.2018,25(2):E276-E278.doi:10.1097/MJT.0000000000000680.
APA:
Wang, Yang,Liu, ShengZhuo,Liu, Shan,Li, Xia,Liu, QiuYan...&Jiang, YongXin.(2018).Regorafenib Treatment for Management of Colorectal Cancer: A Systematic Review and Meta-analysis of 6 Randomized Controlled Trials.AMERICAN JOURNAL OF THERAPEUTICS,25,(2)
MLA:
Wang, Yang,et al."Regorafenib Treatment for Management of Colorectal Cancer: A Systematic Review and Meta-analysis of 6 Randomized Controlled Trials".AMERICAN JOURNAL OF THERAPEUTICS 25..2(2018):E276-E278